Summary
The quantitative distribution of the two main T lymphocyte subsets, recognizable by the ‘high’ and ‘low-affinity’ E rosette-forming cell technique of West, was studied in both the bone marrow and peripheral blood from ten untreated multiple myeloma (MM) patients. A reduced total T lymphocyte count, with a relative predominance of ‘low-affinity’ T lymphocytes (putative suppressor T cells), was found in the peripheral blood. Within a normal total T lymphoid cell count, a predominance of the T lymphocyte subset with ‘low-affinity’ characteristics was also observed in the bone marrow. An inverse correlation, that was statistically significant, was seen between the monoclonal malignant cellular B component and the ‘low-affinity’ T cell percentage in all cases. It is concluded, therefore, that such an imbalance between the ‘high’ and ‘low-affinity’ T subsets, with the latter predominating, could be of importance in the regulation of the growth rate of the monoclonal cellular B component.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abdou N. L., Alavi J. B., Abdou N. I.: Human bone marrow lymphocytes: B and T cell precursors and subpopulations — Blood47, 423, 1976.
Alley C. D., MacDermott R. P.: Investigation of the blastogenic and cytotoxic capabilities of human bone marrow: differences between aspirate and rib marrow — Blood55, 669, 1980.
Beck J. D., Wollner N., Miller D. R., Good R. A., Gupta S.: Imbalance of T cell subpopulations in peripheral blood of children with non-Hodgkin’s malignant lymphoma — Amer. J. Haemat.8, 185, 1980.
Broder S., Humphrey R., Durm M., Blackman M., Meade B., Goldman C., Strober W., Waldmann T. A.: Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma — New Engl. J. Med.293, 887, 1975.
Cacciola E., Giustolisi R., Raimondo V., Guglielmo P., Pagano M. C.: Immunologic features in patients with untreated Hodgkin’s and non-Hodgkin’s lymphomas with respect to histopathologic type and stage — In: 5th Meeting of the International Society of Haematology. European and African Division. Hamburg, August 26–31, 1979. (Abstract IV, p. 54).
Campbell A. E., De Vine J., Azam L., Hamid J., Delamore I. W., McFarlane H.: Lymphocyte transformation in patients with monoclonal paraproteinaemia — Brit. J. Haemat.25, 282, 1973.
Catovsky D., Foa R., Lauria F., Matutes S., Galton D. A. G.: Imbalanced T cell subsets in B-chronic lymphocytic leukemia — In: 18th Congress Int. Soc. Haemat. Montreal, August 16–22, 1980. (Abstract, p. 249).
Chan F. P. H., Osmond D. G.: Maturation of bone marrow lymphocytes — Cell. Immunol.47, 366, 1979.
Chiorazzi N., Fu S. M., Montazeri G., Kunkel H. G., Gee T.: T-cell helper defect in patients with chronic lymphocytic leukemia — J. Immunol.122, 1087, 1979.
Claman N. H.: Bone marrow T cells. II. Thymic dependency — Cell. Immunol.13, 484, 1974.
Dammacco F., Miglietta A., Bonomo L.: Immune function in patients with multiple myeloma. (Delayed cutaneous reactivity and lymphocytes bearing receptors for sheep, human, and mouse erythrocytes) — La Ricerca Clin. Lab.7, 343, 1977.
Faguet G. B.: Mechanisms of lymphocyte activation. The role of suppressor cells in the proliferative responses of chronic lymphatic leukemia lymphocytes — J. clin. Invest.63, 67, 1979.
Fauci A. S.: Human bone marrow lymphocytes. I. Distribution of lymphocyte subpopulations in the bone marrow of normal individuals — J. clin. Invest.56, 98, 1975.
Fauci A. S.: Mechanism of corticosteroid action on lymphocyte subpopulations. I. Redistribution of circulating T and B lymphocytes to the bone marrow — Immunology28, 669, 1975.
Fauci A. S., Balow J. E., Pratt K. R.: Human bone marrow lymphocytes. Cytotoxic effector cells in the bone marrow of normal individuals — J. clin. Invest.57, 826, 1976.
Flood P. M., Philipps C., Taupier M. A., Schreiber H.: Regulation of myeloma growthin vitro by idiotype-specific T lymphocytes — J. Immunol.124, 424, 1980.
Garret J. U., Scharffe J. H., Newton R. K.: Abnormal peripheral blood lymphocytes and bone marrow infiltration in non-Hodgkin’s lymphoma — Brit. J. Haemat.42, 41, 1979.
Hijmans W., Schuit H. R. E., Klein F.: An immunofluorescence procedure for the detection of intracellular immunoglobulins — Clin. exp. Immunol.4, 457, 1969.
Jondal M., Holm G., Wigzell H.: Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells — J. exp. Med.136, 207, 1972.
Jones S. V., McFarlane H.: T and B cells in myelomatosis — Brit. J. Haemat.31, 545, 1975.
Kay N. E., Johnson J. D., Stanek R., Douglas S. D.: T-cell subpopulations in chronic lymphocytic leukemia: abnormalities in distribution andin vitro receptor maturation — Blood54, 540, 1979.
Lauria F., Foa R., Catovsky D.: Increase in Tγ lymphocytes in B cell chronic lymphocytic leukaemia — Scand. J. Haemat.24, 187, 1980.
Mackenzie M. R., Paglieroni T. G.: Plasma cell antigens in human multiple myeloma — J. Lab. clin. Med.89, 1009, 1977.
Mancini G., Carbonara A. O., Heremans J. F.: Immunochemical quantitation of antigens by single radial immunodiffusion — Immunochemistry2, 235, 1965.
Mellstedt H., Hammarstrom S., Holm G.: Monoclonal lymphocyte population in human plasma cell myeloma — Clin. exp. Immunol.17, 371, 1974.
Mellstedt H., Holm G.:In vitro studies of lymphocytes from patients with plasma cell myeloma. I. Stimulation by mitogens and cytotoxic activities — Clin. exp. Immunol.15, 309, 1973.
Mellstedt H., Jondal M., Holm G.:In vitro studies of lymphocytes from patients with plasma cell myeloma. II. Characterization by cell surface markers — Clin. exp. Immunol.15, 321, 1973.
Moretta L., Ferrarini M., Mingari M. C., Moretta A., Webb S. R.: Subpopulations of human T cells identified by receptors for immunoglobulin and mitogen responsiveness — J. Immunol.117, 2171, 1976.
Moretta L., Webb S. R., Grossi C. E., Lydyard P. M., Cooper M. D.: Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG — J. exp. Med.146, 184, 1977.
Morito T., Bankhurst A. D., Williams R. C.: Studies of T- and B-cell interactions in adult patients with combined immunodeficiency — J. clin. Invest.65, 422, 1980.
Paglieroni T. G., Mackenzie M. R.: Studies on the pathogenesis of an immune defect in multiple myeloma — J. clin. Invest.59, 1120, 1977.
Paglieroni T. G., Mackenzie M. R.: Multiple myeloma: an immunologic profile. III. Cytotoxic and suppressor effects of the EA-rosette-forming cell — J. Immunol.124, 2563, 1980.
Reinherz E. L., Moretta L., Roper M., Breard J. M., Mingari M. C., Cooper M. D., Schlossman S. F.: Human T-lymphocyte subpopulations defined by Fc-receptors and monoclonal antibodies — J. exp. Med.151, 969, 1980.
Reinherz E. L., Schlossman S. F.: Regulation of the immune response. Inducer and suppressor T-lymphocyte subsets in human beings — New Engl. J. Med.303, 370, 1980.
Turesson I.: Distribution of immunoglobulin-containing cells in bone marrow and lymphoid tissues in patients with monoclonal gammapathy — Acta med. scand.203, 247, 1978.
West W. H., Payne S. M., Weese J. L., Herberman R. B.: Human T lymphocyte subpopulations: correlation between E-rosette-forming affinity and expression of the Fc receptor — J. Immunol.119, 548, 1977.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Giustolisi, R., Guglielmo, P., Rizzo, M. et al. T lymphocyte subpopulations in the bone marrow and peripheral blood of untreated patients with myeloma. La Ricerca Clin. Lab. 11, 129–137 (1981). https://doi.org/10.1007/BF02886712
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02886712